全文获取类型
收费全文 | 1844324篇 |
免费 | 135711篇 |
国内免费 | 3075篇 |
专业分类
耳鼻咽喉 | 26143篇 |
儿科学 | 62682篇 |
妇产科学 | 49297篇 |
基础医学 | 269796篇 |
口腔科学 | 50518篇 |
临床医学 | 163506篇 |
内科学 | 363012篇 |
皮肤病学 | 41014篇 |
神经病学 | 139901篇 |
特种医学 | 71676篇 |
外国民族医学 | 718篇 |
外科学 | 279388篇 |
综合类 | 39330篇 |
现状与发展 | 3篇 |
一般理论 | 515篇 |
预防医学 | 137806篇 |
眼科学 | 41626篇 |
药学 | 138271篇 |
5篇 | |
中国医学 | 4430篇 |
肿瘤学 | 103473篇 |
出版年
2018年 | 19436篇 |
2017年 | 14793篇 |
2016年 | 16344篇 |
2015年 | 18318篇 |
2014年 | 25458篇 |
2013年 | 38762篇 |
2012年 | 52507篇 |
2011年 | 55472篇 |
2010年 | 33018篇 |
2009年 | 31256篇 |
2008年 | 52487篇 |
2007年 | 56198篇 |
2006年 | 56777篇 |
2005年 | 54612篇 |
2004年 | 53364篇 |
2003年 | 51410篇 |
2002年 | 50319篇 |
2001年 | 91624篇 |
2000年 | 94503篇 |
1999年 | 79619篇 |
1998年 | 21312篇 |
1997年 | 18946篇 |
1996年 | 19492篇 |
1995年 | 18490篇 |
1994年 | 17388篇 |
1993年 | 16083篇 |
1992年 | 62474篇 |
1991年 | 61349篇 |
1990年 | 59747篇 |
1989年 | 57626篇 |
1988年 | 52869篇 |
1987年 | 51690篇 |
1986年 | 48423篇 |
1985年 | 46133篇 |
1984年 | 34377篇 |
1983年 | 28942篇 |
1982年 | 16509篇 |
1981年 | 14915篇 |
1979年 | 30783篇 |
1978年 | 21462篇 |
1977年 | 18164篇 |
1976年 | 17138篇 |
1975年 | 18621篇 |
1974年 | 21762篇 |
1973年 | 20878篇 |
1972年 | 19378篇 |
1971年 | 17781篇 |
1970年 | 16923篇 |
1969年 | 15388篇 |
1968年 | 14113篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Reider N. Issa A. Hawranek T. 《世界核心医学期刊文摘》2006,2(3):48-49
芦荟自古就被用作化妆品和药物添加剂,近来更受喜爱。虽应用广泛,但过敏反应罕有报道。作者用芦荟叶的油性提取物、来自整个植株的芦荟粉及浓缩的芦荟凝胶,对相继就诊的702例患者做斑贴试验。设计专门的问卷调查芦荟的使用、使用原因、使用部位、不良反应、患者职业、个人爱好及是否为遗传性过敏体质。患者均未对任一制剂发生任何反应。需对芦荟所含的两种成分加以鉴别:即芦荟叶皮含有的具有促进肠蠕动、潜在抗菌及抗癌特性的蒽醌类物质。 相似文献
73.
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctive therapy, were observed for 1 year in 202 adult patients, aged 17-83 years, with newly diagnosed or refractory partial epilepsy in clinical practice in Italy. At first observation, the seizure free rate was 72.2% in newly diagnosed patients given monotherapy, 40% in patients in whom oxcarbazepine replaced another monotherapy and 10.3% in patients given oxcarbazepine as adjunctive therapy. At least 50% reduction in seizure frequency was achieved in 90.7, 72 and 57%, respectively. Efficacy increased with the duration of treatment (p < 0.0001). In the 160 completers the seizure free rate was 61.3% with monotherapy and 28% with adjunctive therapy. 16.3% of patients reported adverse effects, mainly sedation and sleepiness; 5% discontinued oxcarbazepine because of adverse events. OXC is an effective and well-tolerated antiepileptic agent for the long-term treatment of partial epilepsy in adults. 相似文献
74.
75.
Zusammenfassung Viele gastrointestinale Tumoren werden im Rahmen multimodaler Therapiekonzepte behandelt. Für den Chirurgen ist die neoadjuvante, präoperative Behandlung von besonderem Interesse, da sie durch therapiebedingte Nebenwirkungen und Komplikationen zu einer Beeinflussung des postoperativen Verlaufs führen kann. Die neoadjuvante Radiochemotherapie ist fester Bestandteil der Therapie beim primären T4-Rektumkarzinom, beim Rektumkarzinomrezidiv und bei tief sitzenden primären Rektumkarzinomen. Durch Erhöhung der R0-Resektionsrate können die lokale Tumorkontrolle verbessert und die Überlebenszeit verlängert werden. Die postoperative Komplikationsrate ist dabei nicht wesentlich erhöht. In der Behandlung des primär resektablen Ösophaguskarzinoms deutet sich ein Vorteil der neoadjuvanten Radiochemotherapie im Vergleich zur alleinigen Chirurgie an. Beim lokal fortgeschrittenen Ösophaguskarzinom bietet die präoperative Radiochemotherapie häufig die einzige Chance zur Resektion, jedoch mit einer deutlich erhöhten postoperativen Morbidität und Mortalität. Die Wirksamkeit und Sicherheit einer neoadjuvanten Chemo- oder kombinierten Radiochemotherapie beim fortgeschrittenen Magenkarzinom wird derzeit im Rahmen von Studienprotokollen untersucht. 相似文献
76.
Published data devoted to making and characterization of the properties of polymeric wound dressings with proteolytic action
are reviewed. These data are indicative of individual dependence of the physicochemical properties, activity, and stability
of each particular enzyme on the type of polymer matrix and the method of immobilization. In order to obtain wound dressings,
which are active in physiological medium and retain their activity upon sterilization, it is necessary to optimize the composition
and characteristics of a polymer matrix and the enzyme included into its structure.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 8, pp. 24–28, August, 2006. 相似文献
77.
78.
K P Sylvester S R Desai A U Wells D M Hansell M Awogbade S L Thein A Greenough 《The European respiratory journal》2006,28(4):832-838
The aim of this study was to determine whether patients with sickle cell disease (SCD) in steady state had pulmonary abnormalities seen on high-resolution computed tomography (HRCT) and whether any abnormalities correlated with contemporaneously diagnosed lung function abnormalities. A subsidiary question was whether the results of a noninvasive measure of haemolysis (end-tidal carbon monoxide (ETCO) levels) correlated with pulmonary function abnormalities. Thirty three patients with SCD, median (range) age 36 yrs (17-67 yrs) were examined. The degree of lobar volume loss and ground-glass opacification and prominence of central vessels on HRCT were quantitatively assessed. Pulmonary function was assessed by measurements of lung volumes, spirometry, gas transfer and oxygen saturation. ETCO levels were measured using an end-tidal CO monitor. Forced expiratory volume in one second (FEV1), forced vital capacity and total lung capacity significantly correlated with HRCT findings, particularly lobar volume loss. ETCO levels significantly negatively correlated with FEV1, vital capacity measured using a plethysmograph, specific airway conductance and arterial oxygen saturation measured by pulse oxymetry. In conclusion, the present results suggest that high-resolution computed tomography noninvasive assessment of haemolysis might be useful to identify sickle cell disease patients with respiratory function impairment. 相似文献
79.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献
80.
N B Pride 《The European respiratory journal》2006,27(1):240-1; author reply 241-2